Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Frank

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Diabetes|August 1, 1983
Characterization of the receptor binding properties of monoiodoinsulin isomers and the identification of different insulin receptor specificities in hepatic and extrahepatic tissuesD A Podlecki, B H Frank, M Kao, et al.
The Biochemical Journal|October 1, 1988
Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytesW C Duckworth, D E Peavy, F G Hamel, et al.
Diabetes|December 1, 1987
Insulin secretion and clearance. Comparison after oral and intravenous glucoseE T Shapiro, H Tillil, M A Miller, et al.
The New England Journal of Medicine|February 19, 1987
The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitusH S Glauber, R R Henry, P Wallace, et al.
Diabetes|March 1, 1988
Immunologic aspects of human proinsulin therapyS E Fineberg, M J Rathbun, S Hufferd, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1987
The effect of biosynthetic human proinsulin on the hepatic response to glucagon in insulin-deficient diabetesR M Cohen, J Licinio, K S Polonsky, et al.
Journal of Pharmaceutical Sciences|September 10, 1999
Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente propertiesJ P Richards, M P Stickelmeyer, B H Frank, et al.
Diabetes Care|May 1, 1992
Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experienceJ A Galloway, S A Hooper, C T Spradlin, et al.
Biochemical and Biophysical Research Communications|September 15, 1987
Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytesW C Duckworth, F G Hamel, J J Liepnieks, et al.
The Journal of Biological Chemistry|February 5, 1988
Degradation products of insulin generated by hepatocytes and by insulin proteaseW C Duckworth, F G Hamel, D E Peavy, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Diabetes|August 1, 1983
Characterization of the receptor binding properties of monoiodoinsulin isomers and the identification of different insulin receptor specificities in hepatic and extrahepatic tissuesD A Podlecki, B H Frank, M Kao, et al.
The Biochemical Journal|October 1, 1988
Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytesW C Duckworth, D E Peavy, F G Hamel, et al.
Diabetes|December 1, 1987
Insulin secretion and clearance. Comparison after oral and intravenous glucoseE T Shapiro, H Tillil, M A Miller, et al.
The New England Journal of Medicine|February 19, 1987
The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitusH S Glauber, R R Henry, P Wallace, et al.
Diabetes|March 1, 1988
Immunologic aspects of human proinsulin therapyS E Fineberg, M J Rathbun, S Hufferd, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1987
The effect of biosynthetic human proinsulin on the hepatic response to glucagon in insulin-deficient diabetesR M Cohen, J Licinio, K S Polonsky, et al.
Journal of Pharmaceutical Sciences|September 10, 1999
Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente propertiesJ P Richards, M P Stickelmeyer, B H Frank, et al.
Diabetes Care|May 1, 1992
Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experienceJ A Galloway, S A Hooper, C T Spradlin, et al.
Biochemical and Biophysical Research Communications|September 15, 1987
Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytesW C Duckworth, F G Hamel, J J Liepnieks, et al.
The Journal of Biological Chemistry|February 5, 1988
Degradation products of insulin generated by hepatocytes and by insulin proteaseW C Duckworth, F G Hamel, D E Peavy, et al.
Pageof 10